Influvac

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Influvac is a sub-unit vaccine produced and marketed by Abbott Laboratories. It contains inactivated purified surface fragments (sub-units) from the three different strains of the influenza virus (A/H1N1, A/H3N2, and Influenza B Virus) that are selected and distributed by the World Health Organization, on the basis of their latest recommendations.[1]

The sub-unit influenza vaccine Influvac has been on the market since the early nineteen-eighties.[1]

References[edit]

  1. ^ a b Giezeman, K.M.; J. Nauta, I.A. de Bruijn, A.M. Palache (2009). "Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity". Vaccine (Elsevier) 27: 2414. doi:10.1016/j.vaccine.2009.02.008.